For the patients with pancreatic cancer, postresection CA19-9 level is revealed as a highly significant predictor of OS in a prospective phase III trial [ 11 ].
← all excerpts
Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy.
1
—
—